Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The 2016 ACR Award Winners Discuss Their Contributions to Rheumatology Research, Education, Patient Care

Richard Quinn  |  Issue: December 2016  |  December 13, 2016

Q: You say you’ve practiced in a Golden Age of treatment options. What’s the next Golden Age going to bring?

A: What I hope [for] in the next 25 years [is that] we have ways to really personalize the choices of our medications, that we find factors that allow us to predict in a differential fashion who is going to respond to what therapy. And even if we have no new therapies, if we had an answer to that question, we would be a long ways forward from where we are, where we essentially continue to do trial and error, finding the right medication or the right combinations of medications to work for our patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Distinguished Clinician Scholar Award

Claire Bombardier, MDClaire Bombardier, MD
Professor of Medicine, University of Toronto; Senior Scientist, Toronto General Hospital Research Institute, University Health Network; Rheumatologist, Mount Sinai Hospital, Toronto, Ontario, Canada

Background: When Dr. Bombardier, a Montreal native, was younger, she was interested in physics, chemistry and mathematics, but her father is a pediatrician, and she heard medicine calling. Dr. Bombardier completed her medical degree at the University of Montreal and her residency at McGill University in Montreal. She was a Robert Wood Johnson Clinical Scholar in economics and rheumatology at Stanford University in Palo Alto, Calif. And she spent 13 years as rheumatology division director at the University of Toronto before switching positions earlier this year.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Still, her background in physics, math and economics informs her work to this day. “Sometimes, progress occurs when you merge knowledge from different disciplines.”

Q: How important is it to focus on best practices and evidence moving forward?

A: Medicine is a mixture of art, tradition and science. It’s very important to keep the art and the experience in it, because not everything can be quantified in medicine, and there is a lot of intuition and understanding of human nature that has to be there. But we must make sure that what we do has evidence, that the treatments we do are safe, the treatments we do are effective and the treatments we use have sustained effectiveness.

Q: What is the biggest change you’d like to see in terms of changing the practice based on evidence?

A: There’s a revolution in the availability of actual data in everyday practice because of the introduction of electronic health records, and there is also an evolution toward big data—whether it’s from the patient, the rheumatologist, mortality registries, birth registries, cancer registries, now they are even looking at Google data. People and pharmacies are buying what kind of drugs? Does that mean there’s an epidemic of flu coming in? We need to start looking at research in a completely new way.

Henry Kunkel Young Investigator Award

Jasvinder Singh, MBBS, MPHJasvinder Singh, MBBS, MPH
Professor of Medicine and Epidemiology, Staff Physician, Birmingham VA Medical Center; Director, UAB Cochrane Musculoskeletal Group Satellite Center; Director, Gout Clinic, University of Alabama Health Services Foundation; Associate Director, Gout and Hyperuricemia Center for Research and Translation (CoRT), University of Alabama at Birmingham, Birmingham, Ala.

Page: 1 2 3 4 5 6 7 8 9 10 11 | Single Page
Share: 

Filed under:Awards Tagged with:AC&RACR/ARHPAmerican College of Rheumatology (ACR)Awardsrheumatologywinner

Related Articles

    The 2019 ACR Award Winners & Distinguished Fellows

    December 18, 2019

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

    The 2021 ACR Awards of Distinction & Distinguished Fellows

    December 16, 2021

    During ACR Convergence 2021 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care, announcing the recipients of the ACR’s 2021 Awards of Distinction, as well as the group of Distinguished Fellows. recognized for their contributions. Three pediatric rheumatologists and one pediatric fellow…

    The ACR/ARHP Award Winners Discuss Their Contributions to Rheumatology

    January 19, 2016

    At the 2015 ACR/ARHP Annual Meeting in San Francisco in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. In the December 2015 issue, The Rheumatologist reported on the ACR’s awards. This month, we speak with the ARHP winners about…

    The 2022 ACR Awards of Distinction

    December 8, 2022

    During ACR Convergence 2022 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care by announcing the recipients of the ACR’s 2022 Awards of Distinction, as well as the 2022 ACR Masters, recognized for their contributions to the field. See the November issue…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences